Hemodiafiltration versus High-flux Hemodialysis and Risk of Mortality: A Multinational Target Trial Emulation

A Fresenius study of almost 20,000 patients in eight European countries from 2014-2019 found that hemodiafiltration (HDF) reduced all-cause mortality risk by 28% over conventional high flux HD. Even better, all-cause mortality was reduced 33% with high volume (23 liters per session) HDF compared with conventional high flux HD.

Read the abstract » | (added 2026-09-18)

Tags: Hemodiafiltration, HDF, All cause Mortality